COVID-19 therapeutics
Clinical Microbiology Reviews · 13.06.2024 · 37 (2)
DOI: 10.1128/cmr.00119-23 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 13.06.2024. Verfasst von Daniele Focosi und 3 weiteren Autor:innen. Beteiligte Einrichtung: North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy. Hauptthemen laut MEDLINE: Antiviral Agents, COVID-19 Drug Treatment, SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 362 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Since the emergence of COVID-19 in 2020, an unprecedented range of therapeutic options has been studied and deployed. Healthcare providers have multiple treatment approaches to choose from, but efficacy of those approaches often remains controversial or compromised by viral evolution. Uncertainties still persist regarding the best therapies for high-risk patients, and the drug pipeline is suffering fatigue and shortage of funding. In this article, we review the antiviral activity, mechanism of action, pharmacokinetics, and safety of COVID-19 antiviral therapies. Additionally, we summarize the evidence from randomized controlled trials on efficacy and safety of the various COVID-19 antivirals and discuss unmet needs which should be addressed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy.
- Division of Hematology and Transfusion Medicine, Carlo Poma Hospital, Mantua, Italy.
- National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Rome, Italy.
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Daniele Focosi, Shmuel Shoham
Zitieren
APA
Focosi, D., Franchini, M., Maggi, F., & Shoham, S. (2024). COVID-19 therapeutics. Clinical Microbiology Reviews, 37(2). https://doi.org/10.1128/cmr.00119-23
Vancouver
Focosi D, Franchini M, Maggi F, Shoham S. COVID-19 therapeutics. Clinical Microbiology Reviews. 2024;37(2). doi:10.1128/cmr.00119-23
BibTeX
@article{Focosi2024,
author = {Focosi, Daniele and Franchini, Massimo and Maggi, Fabrizio and Shoham, Shmuel},
title = {COVID-19 therapeutics},
journal = {Clinical Microbiology Reviews},
year = {2024},
volume = {37},
number = {2},
doi = {10.1128/cmr.00119-23}
}
EUVIMED